FCRL3


Description

The FCRL3 (Fc receptor like 3) is a protein-coding gene located on chromosome 1.

Fc receptor-like protein 3 (FCRL3) is a protein encoded by the FCRL3 gene in humans. It belongs to the immunoglobulin receptor superfamily and is part of a group of Fc receptor-like glycoproteins located on the long arm of chromosome 1. FCRL3 contains both an immunoreceptor-tyrosine activation motif (ITAM) and an immunoreceptor-tyrosine inhibitory motif (ITIM) in its cytoplasmic domain, suggesting a role in regulating the immune system. Mutations in this gene have been linked to autoimmune diseases such as rheumatoid arthritis, autoimmune thyroid disease, and systemic lupus erythematosus. Structurally, FCRL3 is a type I transmembrane glycoprotein with an extracellular region, a transmembrane domain, and a cytoplasmic tail. Its extracellular region comprises five immunoglobulin-like domains that share varying degrees of homology with other Fc receptor-like proteins and Fc receptors FcγRI, FcγRII, and FcγRIII. The transmembrane region is composed of hydrophobic residues and is uncharged. The cytoplasmic region contains two signaling motifs: a membrane-proximal ITAM and a carboxy-proximal ITAM-like motif. The presence of both activating and inhibitory motifs hints at FCRL3's potential for dual signaling.

FCRL3 promotes B-cell proliferation, activation, and survival in response to TLR9 stimulation. It enhances NF-kappa-B and MAPK signaling pathways in TLR9-activated B-cells, but inhibits antibody production and suppresses plasma cell differentiation. FCRL3 also plays an inhibitory role in B-cell receptor (BCR)-mediated signaling, potentially through interactions with SH2 domain-containing phosphatases. This inhibition manifests as reduced tyrosine phosphorylation, calcium mobilization, and activation-induced cell death triggered by BCR signaling. In regulatory T-cells, FCRL3 expression is linked to a memory phenotype, reduced responsiveness to antigenic stimulation in the presence of IL2, and diminished capacity to suppress effector T-cell proliferation. Notably, FCRL3 acts as a human-specific epitope on the surface of oocytes (oolemma) and participates in sperm-egg adhesion and fusion. During fertilization, FCRL3 interacts with the IZUMO1-IZUMO1R/JUNO complex, displacing IZUMO1R/JUNO and acting as the new receptor for IZUMO1, enabling species-specific gamete fusion.

FCRL3 is also known as CD307c, FCRH3, IFGP3, IRTA3, MAIA, SPAP2.

Associated Diseases


Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.